205 related articles for article (PubMed ID: 18264829)
1. Imaging of primary and metastatic pancreatic cancer using a fluorophore-conjugated anti-CA19-9 antibody for surgical navigation.
McElroy M; Kaushal S; Luiken GA; Talamini MA; Moossa AR; Hoffman RM; Bouvet M
World J Surg; 2008 Jun; 32(6):1057-66. PubMed ID: 18264829
[TBL] [Abstract][Full Text] [Related]
2. Metastatic recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) nude mouse model is inhibited by neoadjuvant chemotherapy in combination with fluorescence-guided surgery with an anti-CA 19-9-conjugated fluorophore.
Hiroshima Y; Maawy A; Zhang Y; Murakami T; Momiyama M; Mori R; Matsuyama R; Katz MH; Fleming JB; Chishima T; Tanaka K; Ichikawa Y; Endo I; Hoffman RM; Bouvet M
PLoS One; 2014; 9(12):e114310. PubMed ID: 25463150
[TBL] [Abstract][Full Text] [Related]
3. Toward Curative Fluorescence-Guided Surgery of Pancreatic Cancer.
Bouvet M; Hoffman RM
Hepatogastroenterology; 2015 May; 62(139):715-22. PubMed ID: 26897960
[TBL] [Abstract][Full Text] [Related]
4. Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer.
Houghton JL; Zeglis BM; Abdel-Atti D; Aggeler R; Sawada R; Agnew BJ; Scholz WW; Lewis JS
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15850-5. PubMed ID: 26668398
[TBL] [Abstract][Full Text] [Related]
5. Fluorophore-conjugated anti-CEA antibody for the intraoperative imaging of pancreatic and colorectal cancer.
Kaushal S; McElroy MK; Luiken GA; Talamini MA; Moossa AR; Hoffman RM; Bouvet M
J Gastrointest Surg; 2008 Nov; 12(11):1938-50. PubMed ID: 18665430
[TBL] [Abstract][Full Text] [Related]
6. An engineered anti-CA19-9 cys-diabody for positron emission tomography imaging of pancreatic cancer and targeting of polymerized liposomal nanoparticles.
Girgis MD; Federman N; Rochefort MM; McCabe KE; Wu AM; Nagy JO; Denny C; Tomlinson JS
J Surg Res; 2013 Nov; 185(1):45-55. PubMed ID: 23827791
[TBL] [Abstract][Full Text] [Related]
7. Anti-CA19-9 diabody as a PET imaging probe for pancreas cancer.
Girgis MD; Kenanova V; Olafsen T; McCabe KE; Wu AM; Tomlinson JS
J Surg Res; 2011 Oct; 170(2):169-78. PubMed ID: 21601881
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence-guided surgery with a fluorophore-conjugated antibody to carcinoembryonic antigen (CEA), that highlights the tumor, improves surgical resection and increases survival in orthotopic mouse models of human pancreatic cancer.
Metildi CA; Kaushal S; Pu M; Messer KA; Luiken GA; Moossa AR; Hoffman RM; Bouvet M
Ann Surg Oncol; 2014 Apr; 21(4):1405-11. PubMed ID: 24499827
[TBL] [Abstract][Full Text] [Related]
9. Specific tumor labeling enhanced by polyethylene glycol linkage of near infrared dyes conjugated to a chimeric anti-carcinoembryonic antigen antibody in a nude mouse model of human pancreatic cancer.
Maawy AA; Hiroshima Y; Zhang Y; Luiken GA; Hoffman RM; Bouvet M
J Biomed Opt; 2014; 19(10):101504. PubMed ID: 24887695
[TBL] [Abstract][Full Text] [Related]
10. Hand-held high-resolution fluorescence imaging system for fluorescence-guided surgery of patient and cell-line pancreatic tumors growing orthotopically in nude mice.
Hiroshima Y; Maawy A; Sato S; Murakami T; Uehara F; Miwa S; Yano S; Momiyama M; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
J Surg Res; 2014 Apr; 187(2):510-7. PubMed ID: 24373959
[TBL] [Abstract][Full Text] [Related]
11. Preloading with Unlabeled CA19.9 Targeted Human Monoclonal Antibody Leads to Improved PET Imaging with
Houghton JL; Abdel-Atti D; Scholz WW; Lewis JS
Mol Pharm; 2017 Mar; 14(3):908-915. PubMed ID: 28191976
[TBL] [Abstract][Full Text] [Related]
12. Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer.
Lohrmann C; O'Reilly EM; O'Donoghue JA; Pandit-Taskar N; Carrasquillo JA; Lyashchenko SK; Ruan S; Teng R; Scholz W; Maffuid PW; Lewis JS; Weber WA
Clin Cancer Res; 2019 Dec; 25(23):7014-7023. PubMed ID: 31540979
[TBL] [Abstract][Full Text] [Related]
13. Tumor-specific fluorescence antibody imaging enables accurate staging laparoscopy in an orthotopic model of pancreatic cancer.
Tran Cao HS; Kaushal S; Metildi CA; Menen RS; Lee C; Snyder CS; Messer K; Pu M; Luiken GA; Talamini MA; Hoffman RM; Bouvet M
Hepatogastroenterology; 2012 Sep; 59(118):1994-9. PubMed ID: 22369743
[TBL] [Abstract][Full Text] [Related]
14. Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore.
Lwin TM; Murakami T; Miyake K; Yazaki PJ; Shivley JE; Hoffman RM; Bouvet M
Ann Surg Oncol; 2018 Apr; 25(4):1079-1085. PubMed ID: 29372363
[TBL] [Abstract][Full Text] [Related]
15. Successful fluorescence-guided surgery on human colon cancer patient-derived orthotopic xenograft mouse models using a fluorophore-conjugated anti-CEA antibody and a portable imaging system.
Hiroshima Y; Maawy A; Metildi CA; Zhang Y; Uehara F; Miwa S; Yano S; Sato S; Murakami T; Momiyama M; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
J Laparoendosc Adv Surg Tech A; 2014 Apr; 24(4):241-7. PubMed ID: 24494971
[TBL] [Abstract][Full Text] [Related]
16. An LED light source and novel fluorophore combinations improve fluorescence laparoscopic detection of metastatic pancreatic cancer in orthotopic mouse models.
Metildi CA; Kaushal S; Lee C; Hardamon CR; Snyder CS; Luiken GA; Talamini MA; Hoffman RM; Bouvet M
J Am Coll Surg; 2012 Jun; 214(6):997-1007.e2. PubMed ID: 22542065
[TBL] [Abstract][Full Text] [Related]
17. Targeting the insulin growth factor-1 receptor with fluorescent antibodies enables high resolution imaging of human pancreatic cancer in orthotopic mouse models.
Park JY; Lee JY; Zhang Y; Hoffman RM; Bouvet M
Oncotarget; 2016 Apr; 7(14):18262-8. PubMed ID: 26919100
[TBL] [Abstract][Full Text] [Related]
18. Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody.
Aung W; Tsuji AB; Sugyo A; Takashima H; Yasunaga M; Matsumura Y; Higashi T
World J Gastroenterol; 2018 Dec; 24(48):5491-5504. PubMed ID: 30622378
[TBL] [Abstract][Full Text] [Related]
19. MUC1 selectively targets human pancreatic cancer in orthotopic nude mouse models.
Park JY; Hiroshima Y; Lee JY; Maawy AA; Hoffman RM; Bouvet M
PLoS One; 2015; 10(3):e0122100. PubMed ID: 25815753
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative imaging of metastatic lymph nodes using a fluorophore-conjugated antibody in a HER2/neu-expressing orthotopic breast cancer mouse model.
Wu J; Ma R; Cao H; Wang Z; Jing C; Sun Y; Zhang Y; Yang Z; Hoffman RM; Tang J
Anticancer Res; 2013 Feb; 33(2):419-24. PubMed ID: 23393332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
